FOGICAP 20

• Code: DD-01
• Ingredient : 20 mg omeprazole and 1,680 mg sodium bicarbonate in unit-dose packets
• Point :
  <p><span style="font-size:16px;"><span style="color:#006400;"><span style="font-family:Tahoma,Geneva,sans-serif;">FOGICAP is indicated in adults for the following cases:<br /> Duodenal Ulcer<br /> FOGICAP is indicated for short-term treatment of active duodenal ulcer. Most patients heal within four weeks. Some patients may require an additional four weeks of therapy.<br /> Benign Gastric Ulcer<br /> FOGICAP is indicated for short-term treatment (4-8 weeks) of active benign gastric ulcer.<br /> Gastroesophageal Reflux Disease (GERD)<br /> Treatment of Symptomatic GERD:<br /> FOGICAP is indicated for the treatment of heartburn and other symptoms associated with GERD for up to 4 weeks.<br /> Erosive Esophagitis due to acid-mediated GERD<br /> FOGICAP is indicated for the short-term treatment (4-8 weeks) of erosive esophagitis which has been diagnosed by endoscopy.<br /> The efficacy of FOGICAP used for longer than 8 weeks in these patients has not been established. If a patient does not respond to 8 weeks of treatment, it may be helpful to give up to an additional 4 weeks of treatment. If there is recurrence of erosive esophagitis or GERD symptoms (e.g., heartburn), additional 4-8 week courses of FOGICAP may be considered. <br /> Maintenance of Healing of Erosive Esophagitis due to acid-mediated GERD<br /> FOGICAP is indicated to maintain healing of erosive esophagitis due to acid-mediated GERD. Controlled studies do not extend beyond 12 months. <br /> Reduction of Risk of Upper Gastrointestinal Bleeding in Critically Ill Patients.</span></span></span><span style="font-size:16px;"><span style="color:#006400;"><span style="font-family:Tahoma,Geneva,sans-serif;"></span></span></span></p>